Onemednet

Onemednet Quick Ratio

The Quick Ratio (Acid Test) of Onemednet (ONMD) as of Oct 21, 2026 is 0.36. In the previous year, Quick Ratio (Acid Test) was 0.17 — a change of 109.16% (higher).

Quick Ratio

0.36

YoY

109.16%

Last updated:

Quick Ratio (Acid Test) of Onemednet is 2025 0.36 . Quick Ratio (Acid Test) of Onemednet was 2024 0.17 . It decreases by 109.16% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onemednet Stock analysis

What does Onemednet do? Onemednet Corp generates revenue through its OneMedNet iRWD solution, which curates regulatory-grade Imaging Real World Data (RWD) for healthcare providers and life science companies. The company de-identifies and indexes clinical image archives using AI/ML technology, including EHR, radiology, cardiology, lab, and path data, enabling providers to unlock internal and third-party research opportunities. It offers both customized data packages and pre-packaged regulatory-grade imaging RWD sets to meet rigorous life science requirements. Life science companies and healthcare providers are the primary buyers of these data solutions, leveraging the federated network of healthcare providers for research and development purposes. The company's technology allows for advanced search and curation of medical imaging data, supported by in-house clinical expertise. By processing data locally at network sites, OneMedNet iRWD ensures compliance with regulatory standards while providing access to a wealth of internal and third-party research opportunities. Healthcare providers utilize the solution to enhance their data utilization, while life science firms purchase the pre-packaged RWD sets for clinical trials and product development. The solution's focus on AI/ML-driven indexing and regulatory-grade curation differentiates it in the healthcare data market. OneMedNet iRWD serves as a bridge between healthcare providers' internal data archives and life science research needs. The company's approach to de-identifying and curating data locally ensures privacy and compliance, which is critical for regulatory-grade data. Buyers include life science companies requiring RWD for drug development and healthcare providers seeking to monetize their imaging data. The solution's ability to integrate with various clinical data types, such as EHR, radiology, and lab systems, broadens its appeal across multiple healthcare segments. Onemednet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onemednet stock

Quick Ratio (Acid Test) of Onemednet is 0.36 in 2025.

Quick Ratio (Acid Test) of Onemednet changed from 0.17 to 0.36, representing a 109.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Onemednet since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Onemednet with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Onemednet

All Key Metrics — Onemednet